Details of issuance or disposal
Issuance of the 25th Series Stock Acquisition Rights through a third-party allotment, with provisions for exercise price adjustments (this disclosure reports the monthly exercise status)
Number of shares delivered during the month under review: 49,300 shares (new shares: 49,300 shares; transferred treasury shares: 0 shares)
Exercise ratio under the exercise restrictions: 0.14% (49,300 shares delivered across all series / 34,666,419 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 25th Series Stock Acquisition Rights through a third-party allotment, with provisions for exercise price adjustments (this disclosure reports the monthly exercise status) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month under review: 49,300 shares (new shares: 49,300 shares; transferred treasury shares: 0 shares) |
| Dilution Rate | Exercise ratio under the exercise restrictions: 0.14% (49,300 shares delivered across all series / 34,666,419 listed shares outstanding as of the payment date for the issuance) |
| Exercise price | Exercise prices during the month under review: ¥212.43, ¥213.40, ¥219.22, ¥223.10, ¥221.16, ¥226.01, ¥224.07, ¥226.98, ¥230.86, ¥228.92, ¥219.22, ¥227.95, ¥226.01, ¥225.04, ¥226.01, ¥226.98, ¥224.07 and ¥228.92. Provisions for exercise price adjustments apply. Floor: Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 86,000 rights; unexercised at the end of the preceding month: 38,426 rights; unexercised at the end of the month under review: 37,933 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 8 December 2025: Issuance of the 25th Series Stock Acquisition Rights with provisions for exercise price adjustments. Total issued: 86,000 rights. Issue price and funds raised: Not disclosed |
Items this document does not state (21)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reports the monthly exercise status for August 2026 of the 25th Series Stock Acquisition Rights issued on 8 December 2025.